Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    Proffered Paper session III

    • Type: Proffered Paper session
    • Presentations: 8
    • Coordinates: 4/12/2019, 08:30 - 10:00, Room A
    • +

      84O - Phase I study of gefitinib (G) + durvalumab (D) for locally advanced/metastatic non-small cell lung cancer (NSCLC) harbouring epidermal growth factor receptor (EGFR) sensitising mutations

      08:30 - 08:42  |  Author(s): Benjamin C Creelan

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.